50 related articles for article (PubMed ID: 1973713)
1. Changes in DNA content of lung adenocarcinoma cells following exposure to anti-cancer drugs.
Yang SC; Kuo SH
J Formos Med Assoc; 1990 Jan; 89(1):6-11. PubMed ID: 1973713
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
Fujikane T; Shimizu T; Tsuji T; Ishida S; Ohsaki Y; Onodera S
Cytometry; 1989 Nov; 10(6):788-95. PubMed ID: 2582970
[TBL] [Abstract][Full Text] [Related]
3. [In vitro drug sensitivity testing and chemotherapy of lung cancer].
Liao ML
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):345-6, 374. PubMed ID: 8033231
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor induces doxorubicin resistance to lung cancer cells in vitro.
Prewitt TW; Matthews W; Chaudhri G; Pogrebniak HW; Pass HI
J Thorac Cardiovasc Surg; 1994 Jan; 107(1):43-9. PubMed ID: 8283917
[TBL] [Abstract][Full Text] [Related]
5. Lung adenocarcinoma is more sensitive than gastric adenocarcinoma to anticancer drugs in vitro.
Kohnoe S; Moriguchi S; Emi Y; Sakaguchi Y; Maehara Y; Ishida T; Mitsudomi T; Sugimachi K
Eur J Surg Oncol; 1991 Feb; 17(1):47-50. PubMed ID: 1995357
[TBL] [Abstract][Full Text] [Related]
6. [Effect of calmodulin antagonist on chemosensitivity of primary cultured lung cancer cells].
Xiong W; Shen H
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):347-9. PubMed ID: 8697972
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant.
Chau Q; Stewart DJ
Cancer Chemother Pharmacol; 1999; 44(3):193-202. PubMed ID: 10453720
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
[TBL] [Abstract][Full Text] [Related]
9. Correlation of in vitro chemosensitivity and clinical responses to anticancer drugs in primary adenocarcinoma of the lung.
Yang SC
J Formos Med Assoc; 1990 Mar; 89(3):214-9. PubMed ID: 1974594
[TBL] [Abstract][Full Text] [Related]
10. Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.
Wang Z; Ma LJ; Kang Y; Li X; Zhang XJ
Oncol Rep; 2015 Mar; 33(3):1097-106. PubMed ID: 25573172
[TBL] [Abstract][Full Text] [Related]
11. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
Giaccone G; Gazdar AF; Beck H; Zunino F; Capranico G
Cancer Res; 1992 Apr; 52(7):1666-74. PubMed ID: 1312895
[TBL] [Abstract][Full Text] [Related]
12. [Chemosensitivity test for 170 human breast carcinoma samples].
He Z; Yuan J; Chen Z; Liu S; Shen Z; Fei H
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):531-4. PubMed ID: 10806759
[TBL] [Abstract][Full Text] [Related]
13. [Application of simultaneous flow cytometric bromodeoxyuridine (BrdU)/DNA analysis. 2. Basic study to apply as a chemosensitivity test].
Shimabukuro T
Hinyokika Kiyo; 1988 Aug; 34(8):1349-55. PubMed ID: 3195402
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.
Fink D; Zheng H; Nebel S; Norris PS; Aebi S; Lin TP; Nehmé A; Christen RD; Haas M; MacLeod CL; Howell SB
Cancer Res; 1997 May; 57(10):1841-5. PubMed ID: 9157971
[TBL] [Abstract][Full Text] [Related]
15. Calpain-mediated pathway dominates cisplatin-induced apoptosis in human lung adenocarcinoma cells as determined by real-time single cell analysis.
Liu L; Xing D; Chen WR; Chen T; Pei Y; Gao X
Int J Cancer; 2008 May; 122(10):2210-22. PubMed ID: 18214855
[TBL] [Abstract][Full Text] [Related]
16. [Chemosensitivity test for lung cancer].
Nishio K; Saijo N
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):225-31. PubMed ID: 2355692
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
Moritaka T; Kiura K; Ueoka H; Tabata M; Segawa Y; Shibayama T; Takigawa N; Ohnoshi T; Harada M
Anticancer Res; 1998; 18(2A):927-33. PubMed ID: 9615743
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced DNA hypermethylation and drug resistance in human tumors.
Nyce J
Cancer Res; 1989 Nov; 49(21):5829-36. PubMed ID: 2790794
[TBL] [Abstract][Full Text] [Related]
19. In vitro efficacy of chemotherapeutics as determined by 50% inhibitory concentrations in cell cultures of mammary gland tumors obtained from dogs.
Simon D; Knebel JW; Baumgartner W; Aufderheide M; Meyer-Lindenberg A; Nolte I
Am J Vet Res; 2001 Nov; 62(11):1825-30. PubMed ID: 11703031
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
Lai SL; Hwang J; Perng RP; Whang-Peng J
Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]